About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

FOUND - Ancillary Study to Smile Protocol NCT03654105

NCT04441814·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

With

University of Parma
University of Milan
University of Milano Bicocca

Age

50–75

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Elegibility to annual LDCT screening
Absence of tumors for at least 5 years

You may not be if

Hypersensitivity to acetylsalicylic acid, salicylates or any of the excipients
Chronic treatment with acetylsalicylic acid, or other anti-clotting or anti-coagulant drugs
Treatment with methotrexate
Existing Mastocytosis
History of asthma induced by the administration of salicylates or substances to similar activity, particularly non-steroidal anti-inflammatory drugs
Gastroduodenal ulcer
Hemorrhagic diathesis
Severe chronic pathology
Serious psychiatric problems
Previous treatment with Cytisine
Abuse of alcohol or other substances

The record

StatusUnknown

PhaseNo phase

Taking part960

StartedJul 2019

UpdatedMar 7, 2024

Conditions

COVID 19 Inflammatory Status

Where1

Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy

Clareo Health | FOUND - Ancillary Study to Smile Protocol NCT03654105